Aurobindo Pharma Ltd. | AUROPHARMA | NSE - Pharmaceuticals


Performance  |  Valuation  |  Growth  |  Insiders  |  Summary

Financial Summary Report of Aurobindo Pharma Ltd.



AUROPHARMA
Aurobindo Pharma Ltd.

Rs. 772.65
30-Oct-2020

5 Yr Performance

1 Yr Performance

Valuation




Analysis




Quarterly Revenue, Net Income and Adjusted Share Price




Peer Comparison


AstraZenca Pharma India Ltd.

Biocon Ltd.

Cadila Healthcare Ltd.

Cipla Ltd.

RPG Life Sciences Limited

Divis Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

FDC Ltd.

Fresenius Kabi Oncology Ltd.

Glaxosmithkline Pharmaceuticals Ltd.